nodes	percent_of_prediction	percent_of_DWPC	metapath
Adinazolam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.0384	0.0702	CbGeAlD
Adinazolam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0333	0.0608	CbGeAlD
Adinazolam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.032	0.0586	CbGeAlD
Adinazolam—GABRR3—nerve—amyotrophic lateral sclerosis	0.0299	0.0547	CbGeAlD
Adinazolam—GABRR2—nerve—amyotrophic lateral sclerosis	0.0259	0.0474	CbGeAlD
Adinazolam—GABRR1—nerve—amyotrophic lateral sclerosis	0.025	0.0457	CbGeAlD
Adinazolam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.0156	0.0284	CbGeAlD
Adinazolam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.0115	0.0209	CbGeAlD
Adinazolam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.0106	0.805	CrCbGaD
Adinazolam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.0105	0.0191	CbGeAlD
Adinazolam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.0101	0.0185	CbGeAlD
Adinazolam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00892	0.0163	CbGeAlD
Adinazolam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00673	0.0123	CbGeAlD
Adinazolam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00656	0.012	CbGeAlD
Adinazolam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.0065	0.0119	CbGeAlD
Adinazolam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00625	0.0114	CbGeAlD
Adinazolam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.00606	0.0111	CbGeAlD
Adinazolam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.006	0.011	CbGeAlD
Adinazolam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00589	0.0108	CbGeAlD
Adinazolam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00583	0.0107	CbGeAlD
Adinazolam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.0058	0.0106	CbGeAlD
Adinazolam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00567	0.0104	CbGeAlD
Adinazolam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00562	0.0103	CbGeAlD
Adinazolam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.00558	0.0102	CbGeAlD
Adinazolam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00549	0.01	CbGeAlD
Adinazolam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00541	0.00989	CbGeAlD
Adinazolam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00541	0.00989	CbGeAlD
Adinazolam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00488	0.00892	CbGeAlD
Adinazolam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.0047	0.00859	CbGeAlD
Adinazolam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.0047	0.00859	CbGeAlD
Adinazolam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00467	0.00854	CbGeAlD
Adinazolam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00459	0.0084	CbGeAlD
Adinazolam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00458	0.00837	CbGeAlD
Adinazolam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00458	0.00837	CbGeAlD
Adinazolam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00456	0.00833	CbGeAlD
Adinazolam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00453	0.00829	CbGeAlD
Adinazolam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00452	0.00827	CbGeAlD
Adinazolam—GABRG3—brain—amyotrophic lateral sclerosis	0.00451	0.00824	CbGeAlD
Adinazolam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.0045	0.00822	CbGeAlD
Adinazolam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00442	0.00808	CbGeAlD
Adinazolam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.0044	0.00804	CbGeAlD
Adinazolam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00439	0.00802	CbGeAlD
Adinazolam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00436	0.00798	CbGeAlD
Adinazolam—GABRR1—brain—amyotrophic lateral sclerosis	0.00429	0.00785	CbGeAlD
Adinazolam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00429	0.00784	CbGeAlD
Adinazolam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00422	0.00771	CbGeAlD
Adinazolam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00411	0.00752	CbGeAlD
Adinazolam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00408	0.00746	CbGeAlD
Adinazolam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00408	0.00746	CbGeAlD
Adinazolam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00406	0.00743	CbGeAlD
Adinazolam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.00404	0.00739	CbGeAlD
Adinazolam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00396	0.00724	CbGeAlD
Adinazolam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00387	0.00707	CbGeAlD
Adinazolam—GABRD—brain—amyotrophic lateral sclerosis	0.00373	0.00682	CbGeAlD
Adinazolam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.0036	0.00659	CbGeAlD
Adinazolam—GABRG1—brain—amyotrophic lateral sclerosis	0.00359	0.00657	CbGeAlD
Adinazolam—GABRA6—brain—amyotrophic lateral sclerosis	0.00357	0.00653	CbGeAlD
Adinazolam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00351	0.00643	CbGeAlD
Adinazolam—GABRB1—brain—amyotrophic lateral sclerosis	0.00348	0.00637	CbGeAlD
Adinazolam—GABRA5—brain—amyotrophic lateral sclerosis	0.00346	0.00633	CbGeAlD
Adinazolam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.00344	0.00629	CbGeAlD
Adinazolam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.00344	0.00629	CbGeAlD
Adinazolam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00331	0.00605	CbGeAlD
Adinazolam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00331	0.00605	CbGeAlD
Adinazolam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.00324	0.00592	CbGeAlD
Adinazolam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.00324	0.00592	CbGeAlD
Adinazolam—GABRA3—brain—amyotrophic lateral sclerosis	0.00322	0.0059	CbGeAlD
Adinazolam—GABRA4—brain—amyotrophic lateral sclerosis	0.00314	0.00575	CbGeAlD
Adinazolam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00314	0.00575	CbGeAlD
Adinazolam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00313	0.00573	CbGeAlD
Adinazolam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00312	0.0057	CbGeAlD
Adinazolam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.00304	0.00555	CbGeAlD
Adinazolam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.00302	0.00553	CbGeAlD
Adinazolam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.003	0.00548	CbGeAlD
Adinazolam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00296	0.00541	CbGeAlD
Adinazolam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00292	0.00535	CbGeAlD
Adinazolam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00286	0.00522	CbGeAlD
Adinazolam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00264	0.00483	CbGeAlD
Adinazolam—GABRB2—brain—amyotrophic lateral sclerosis	0.00263	0.00481	CbGeAlD
Adinazolam—GABRG2—brain—amyotrophic lateral sclerosis	0.00263	0.00481	CbGeAlD
Adinazolam—Clomipramine—GSTP1—amyotrophic lateral sclerosis	0.00258	0.195	CrCbGaD
Adinazolam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00254	0.00465	CbGeAlD
Adinazolam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00249	0.00454	CbGeAlD
Adinazolam—GABRA2—brain—amyotrophic lateral sclerosis	0.0024	0.00439	CbGeAlD
Adinazolam—GABRE—brain—amyotrophic lateral sclerosis	0.00238	0.00435	CbGeAlD
Adinazolam—GABRA1—brain—amyotrophic lateral sclerosis	0.00232	0.00424	CbGeAlD
Adinazolam—GABRB3—brain—amyotrophic lateral sclerosis	0.00202	0.00369	CbGeAlD
Adinazolam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00135	0.00247	CbGeAlD
Adinazolam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.0013	0.00238	CbGeAlD
Adinazolam—GABRB1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00128	0.00291	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00127	0.00289	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00127	0.00288	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00127	0.00288	CbGpPWpGaD
Adinazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00125	0.00284	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00125	0.00284	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00125	0.00284	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00124	0.00283	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00124	0.00282	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00123	0.00279	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00122	0.00278	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00122	0.00277	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00121	0.00276	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00121	0.00275	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00121	0.00275	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00121	0.00275	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00121	0.00275	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00121	0.00275	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00121	0.00274	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0012	0.00272	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0012	0.00272	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0012	0.00272	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00119	0.00272	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.00119	0.0027	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00118	0.00267	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00118	0.00267	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00117	0.00266	CbGpPWpGaD
Adinazolam—GABRG3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00116	0.00263	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00115	0.00262	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00115	0.00262	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—MAPT—amyotrophic lateral sclerosis	0.00115	0.00262	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00114	0.0026	CbGpPWpGaD
Adinazolam—GABRB1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00114	0.00259	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00113	0.00257	CbGpPWpGaD
Adinazolam—GABRR1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00113	0.00257	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00112	0.00255	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00112	0.00254	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00111	0.00251	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0011	0.00251	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0011	0.00249	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00109	0.00249	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00109	0.00249	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00109	0.00248	CbGpPWpGaD
Adinazolam—GABRA6—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00245	CbGpPWpGaD
Adinazolam—GABRR2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00108	0.00245	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00108	0.00245	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00108	0.00245	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00107	0.00244	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00107	0.00243	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.00107	0.00243	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.00107	0.00243	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.00107	0.00243	CbGpPWpGaD
Adinazolam—GABRA4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00107	0.00242	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00106	0.00242	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00106	0.00242	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00106	0.00242	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00106	0.0024	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00106	0.0024	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00104	0.00237	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00104	0.00237	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00104	0.00236	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00103	0.00234	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00103	0.00234	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00103	0.00233	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00103	0.00233	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00102	0.00232	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00102	0.00232	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00102	0.00232	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00101	0.0023	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.001	0.00227	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.001	0.00227	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000998	0.00227	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000996	0.00226	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000996	0.00226	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000992	0.00225	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000986	0.00224	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000986	0.00224	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000981	0.00223	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000981	0.00223	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000977	0.00222	CbGpPWpGaD
Adinazolam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000975	0.00222	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000974	0.00221	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000963	0.00219	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000958	0.00218	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000957	0.00218	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000951	0.00216	CbGpPWpGaD
Adinazolam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000947	0.00215	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000941	0.00214	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00094	0.00214	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000934	0.00212	CbGpPWpGaD
Adinazolam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00093	0.00211	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000928	0.00211	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000928	0.00211	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000924	0.0021	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000918	0.00209	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000916	0.00208	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000916	0.00208	CbGpPWpGaD
Adinazolam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000914	0.00208	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000911	0.00207	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.00091	0.00207	CbGpPWpGaD
Adinazolam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000908	0.00206	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000902	0.00205	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000902	0.00205	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000899	0.00204	CbGpPWpGaD
Adinazolam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000892	0.00203	CbGpPWpGaD
Adinazolam—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000888	0.00202	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000884	0.00201	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000876	0.00199	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000875	0.00199	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000875	0.00199	CbGpPWpGaD
Adinazolam—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000874	0.00199	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00086	0.00196	CbGpPWpGaD
Adinazolam—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000856	0.00195	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000845	0.00192	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00084	0.00191	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000838	0.00191	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000838	0.00191	CbGpPWpGaD
Adinazolam—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000827	0.00188	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000825	0.00187	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000822	0.00187	CbGpPWpGaD
Adinazolam—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000817	0.00186	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000816	0.00185	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000814	0.00185	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000814	0.00185	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000802	0.00182	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0008	0.00182	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0008	0.00182	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000799	0.00182	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000788	0.00179	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000786	0.00179	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000786	0.00179	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000785	0.00178	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000781	0.00177	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000781	0.00177	CbGpPWpGaD
Adinazolam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000779	0.00177	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000771	0.00175	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000767	0.00174	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000767	0.00174	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000766	0.00174	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000765	0.00174	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000752	0.00171	CbGpPWpGaD
Adinazolam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000747	0.0017	CbGpPWpGaD
Adinazolam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000726	0.00165	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000721	0.00164	CbGpPWpGaD
Adinazolam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000713	0.00162	CbGpPWpGaD
Adinazolam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0007	0.00159	CbGpPWpGaD
Adinazolam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000696	0.00158	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000686	0.00156	CbGpPWpGaD
Adinazolam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000683	0.00155	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000682	0.00155	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000682	0.00155	CbGpPWpGaD
Adinazolam—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000673	0.00153	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00067	0.00152	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00067	0.00152	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000658	0.00149	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00065	0.00148	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00065	0.00148	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00063	0.00143	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00062	0.00141	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000609	0.00138	CbGpPWpGaD
Adinazolam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000607	0.00138	CbGpPWpGaD
Adinazolam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000597	0.00136	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000587	0.00133	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000579	0.00132	CbGpPWpGaD
Adinazolam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000579	0.00132	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000552	0.00125	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000535	0.00122	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000535	0.00122	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00053	0.0012	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000527	0.0012	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000527	0.0012	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000515	0.00117	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000506	0.00115	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000499	0.00113	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000499	0.00113	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000497	0.00113	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000494	0.00112	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000493	0.00112	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000493	0.00112	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000485	0.0011	CbGpPWpGaD
Adinazolam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000477	0.00108	CbGpPWpGaD
Adinazolam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00047	0.00107	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000469	0.00107	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000451	0.00102	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000451	0.00102	CbGpPWpGaD
Adinazolam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000445	0.00101	CbGpPWpGaD
Adinazolam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000439	0.000998	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000438	0.000995	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000438	0.000995	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00043	0.000977	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00043	0.000977	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000429	0.000975	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000424	0.000963	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000422	0.00096	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000422	0.00096	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00042	0.000954	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00042	0.000954	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000412	0.000937	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000412	0.000937	CbGpPWpGaD
Adinazolam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000402	0.000913	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000399	0.000906	CbGpPWpGaD
Adinazolam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00039	0.000887	CbGpPWpGaD
Adinazolam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000383	0.000871	CbGpPWpGaD
Adinazolam—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000379	0.000862	CbGpPWpGaD
Adinazolam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000377	0.000856	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000375	0.000852	CbGpPWpGaD
Adinazolam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000374	0.00085	CbGpPWpGaD
Adinazolam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000367	0.000835	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000366	0.000832	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00036	0.000819	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00036	0.000819	CbGpPWpGaD
Adinazolam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000343	0.000779	CbGpPWpGaD
Adinazolam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000321	0.00073	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000276	0.000627	CbGpPWpGaD
Adinazolam—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000273	0.000619	CbGpPWpGaD
Adinazolam—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000269	0.000611	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000257	0.000584	CbGpPWpGaD
Adinazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000234	0.000532	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000209	0.000475	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000209	0.000475	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000195	0.000443	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000191	0.000434	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000178	0.000404	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000167	0.000379	CbGpPWpGaD
Adinazolam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000164	0.000373	CbGpPWpGaD
Adinazolam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000162	0.000367	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.000151	0.000343	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000126	0.000285	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000126	0.000285	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000115	0.000261	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000114	0.00026	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000107	0.000243	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	0.000106	0.00024	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0001	0.000228	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.62e-05	0.000219	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	9.08e-05	0.000206	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	8.67e-05	0.000197	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.91e-05	0.00018	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	6.88e-05	0.000156	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	6.35e-05	0.000144	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.42e-05	0.000123	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	5.21e-05	0.000119	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.66e-05	0.000106	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.28e-05	9.74e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	3.52e-05	8.01e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.8e-05	6.37e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.58e-05	5.85e-05	CbGpPWpGaD
Adinazolam—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.41e-05	5.49e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.12e-05	4.82e-05	CbGpPWpGaD
Adinazolam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.45e-05	3.3e-05	CbGpPWpGaD
